Tardive dyskinesia: characterization and prevalence in a statewide system
- PMID: 580260
Tardive dyskinesia: characterization and prevalence in a statewide system
Abstract
The prevalence of tardive dyskinesia in a state-wide mental hospital system was assessed using a new quantitative rating scale and related to demographic, medication, and medical history variables. Twenty-six percent of patients had definite signs of tardive dyskinesia, about 12% moderately severe dyskinesia, and 40% exhibited at least some minimal symptoms. Tardive dyskinesia significantly increased with age, and females had a slightly but significantly greater prevalence rate than males. There was no difference in dyskinesia prevalence between patients on or off neuroleptics at time of rating, but patients on multiple neuroleptic drugs had higher prevalence of moderately severe dyskinesia.
Similar articles
-
Epidemiology of tardive dyskinesia. Part II.Dis Nerv Syst. 1976 May;37(5):257-61. Dis Nerv Syst. 1976. PMID: 1261344
-
[Tardive Dyskinesia induced by neuroleptics: a survey of 3140 patients in a psychiatric hospital].Encephale. 1977;3(4):299-320. Encephale. 1977. PMID: 611013 French.
-
Prevalence of tardive dyskinesia.J Clin Psychiatry. 1979 Dec;40(12):508-16. J Clin Psychiatry. 1979. PMID: 40964 Review.
-
[Observations of the course of patients with hyperkinesis].Psychiatr Neurol Med Psychol (Leipz). 1977 Nov;29(11):689-95. Psychiatr Neurol Med Psychol (Leipz). 1977. PMID: 605191 German.
-
Prevalence of tardive dyskinesia in private psychiatric inpatients.Tex Med. 1989 Jan;85(1):25-8. Tex Med. 1989. PMID: 2564217 Review.
Cited by
-
Ineffectiveness of deanol in tardive dyskinesia: a placebo controlled study.Psychopharmacology (Berl). 1979 Nov;65(3):219-23. doi: 10.1007/BF00492207. Psychopharmacology (Berl). 1979. PMID: 117492 Clinical Trial.
-
Persistent catalepsy associated with severe dyskinesias in rats treated with chronic injections of haloperidol decanoate.Psychopharmacology (Berl). 1995 Mar;118(2):142-9. doi: 10.1007/BF02245832. Psychopharmacology (Berl). 1995. PMID: 7617800